Ming, J.; Xu, Q.; Gao, L.; Deng, Y.; Yin, J.; Zhou, Q.; Tong, Q.; Zhang, Y.
Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis. Pharmaceuticals 2021, 14, 452.
https://doi.org/10.3390/ph14050452
AMA Style
Ming J, Xu Q, Gao L, Deng Y, Yin J, Zhou Q, Tong Q, Zhang Y.
Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis. Pharmaceuticals. 2021; 14(5):452.
https://doi.org/10.3390/ph14050452
Chicago/Turabian Style
Ming, Jiaxiong, Qianqian Xu, Limin Gao, Yanfang Deng, Jie Yin, Qun Zhou, Qingyi Tong, and Yonghui Zhang.
2021. "Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis" Pharmaceuticals 14, no. 5: 452.
https://doi.org/10.3390/ph14050452
APA Style
Ming, J., Xu, Q., Gao, L., Deng, Y., Yin, J., Zhou, Q., Tong, Q., & Zhang, Y.
(2021). Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis. Pharmaceuticals, 14(5), 452.
https://doi.org/10.3390/ph14050452
